Globus Medical Valuation
| GMED Stock | USD 73.58 0.24 0.33% |
At this time, the firm appears to be fairly valued. Globus Medical retains a regular Real Value of $71.14 per share. The prevalent price of the firm is $73.58. Our model calculates the value of Globus Medical from evaluating the firm fundamentals such as Return On Asset of 0.0533, return on equity of 0.0252, and Current Valuation of 9.57 B as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Globus Medical's price fluctuation is very steady at this time. Calculation of the real value of Globus Medical is based on 3 months time horizon. Increasing Globus Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Globus stock is determined by what a typical buyer is willing to pay for full or partial control of Globus Medical. Since Globus Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Globus Stock. However, Globus Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 73.58 | Real 71.14 | Hype 73.34 | Naive 70.57 |
The real value of Globus Stock, also known as its intrinsic value, is the underlying worth of Globus Medical Company, which is reflected in its stock price. It is based on Globus Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Globus Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Globus Medical helps investors to forecast how Globus stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Globus Medical more accurately as focusing exclusively on Globus Medical's fundamentals will not take into account other important factors: Globus Medical Total Value Analysis
Globus Medical is currently forecasted to have valuation of 9.57 B with market capitalization of 9.92 B, debt of 537.19 M, and cash on hands of 408.01 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Globus Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.57 B | 9.92 B | 537.19 M | 408.01 M |
Globus Medical Investor Information
About 82.0% of the company shares are owned by institutional investors. The book value of Globus Medical was currently reported as 30.4. The company has Price/Earnings To Growth (PEG) ratio of 1.91. Globus Medical had not issued any dividends in recent years. Globus Medical is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Globus Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Globus Medical has an asset utilization ratio of 47.97 percent. This indicates that the Company is making $0.48 for each dollar of assets. An increasing asset utilization means that Globus Medical is more efficient with each dollar of assets it utilizes for everyday operations.Globus Medical Ownership Allocation
Globus Medical has a total of 115.11 Million outstanding shares. The majority of Globus Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Globus Medical to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Globus Medical. Please pay attention to any change in the institutional holdings of Globus Medical as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Globus Medical Profitability Analysis
The company reported the previous year's revenue of 2.52 B. Net Income was 102.98 M with profit before overhead, payroll, taxes, and interest of 1.7 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Globus Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Globus Medical and how it compares across the competition.
About Globus Medical Valuation
The stock valuation mechanism determines Globus Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Globus Medical. We calculate exposure to Globus Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Globus Medical's related companies.Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Globus Medical operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 2400 people.
Globus Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Globus Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 137.9 M | |
| Quarterly Earnings Growth Y O Y | 0.827 | |
| Forward Price Earnings | 20.9644 |
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |